Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication. (Q51052599)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2011

Language	Label	Description	Also known as
English	Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.	scientific article published in March 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Hong-Long Wang

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Herng-Der Chern

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Bor-Ru Lin

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Chun-Jung Lin

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Teh-Hong Wang

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

language of work or name

0 references

publication date

1 March 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Pharmacotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

227-238

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Helicobacter pyloriInfection

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

H pylori antibiotic resistance: prevalence, importance, and advances in testing

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Eradication therapy for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Time-dependent amplified pharmacokinetic and pharmacodynamic responses of rabeprazole in cytochrome P450 2C19 poor metabolizers

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Eradication of Helicobacter pylori: an objective assessment of current therapies

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Bactericidal and morphological effects of amoxicillin on Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.3.227

21 January 2018

Identifiers

10.1592/PHCO.31.3.227

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21361732%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51052599&oldid=2112203910"